Illumina closes $8bn acquisition of cancer detection tests provider GRAIL
Illumina will operate GRAIL as a separate entity, as the transaction is currently under European Commission (EC)’s regulatory…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
19 Aug 21
Illumina will operate GRAIL as a separate entity, as the transaction is currently under European Commission (EC)’s regulatory…
19 Aug 21
Latest Addition to the Kosmos Platform Now Enables Full-Body Imaging at Point-of-Care in a Hand-Carried Device
19 Aug 21
DePuy Synthes acquired the INHANCE Shoulder System through a multi-year, strategic agreement with Ignite Orthopedics
19 Aug 21
The CardioNXT technology platform enables the examination of problematic cardiac tissue
18 Aug 21
The SDNA-1000 saliva collection device serves as a noninvasive way to collect, neutralise, stabilise, and transport testing samples
18 Aug 21
TALi’s patented technology uses new mechanisms specifically designed to evaluate, target and enhance attention in early childhood aged…
18 Aug 21
Neovasc has supplemented the protocol for the previously approved COSIRA-II study, after discussions with the US FDA for…
18 Aug 21
New 7mm insertion profile is combined with company’s proprietary Adaptive Geometry technology
18 Aug 21
The FASTSEAL 6.0 Wand aims to support surgeons to overcome those challenges while managing patient outcomes